Lignan compound in herba portulacae and extraction and separation method and application of lignan compound

A technology of lignans and separation method, which is applied in the field of extraction and separation of lignans, can solve the problems of low structural novelty and the like, and achieves the effects of environmental protection of the process method, simple and fast operation method

Active Publication Date: 2021-02-02
LIAONING UNIV OF TRADITIONAL CHINESE MEDICINE
View PDF3 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] At present, most of the chemical components isolated from purslane are known, and the structural novelty is low. Therefore, the development and isolation of new compounds in purslane are urgently needed

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Lignan compound in herba portulacae and extraction and separation method and application of lignan compound
  • Lignan compound in herba portulacae and extraction and separation method and application of lignan compound
  • Lignan compound in herba portulacae and extraction and separation method and application of lignan compound

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0036] Example 1 Extracting and separating lignans from purslane and its extraction and separation method.

[0037] A kind of lignan compound extracted and separated from purslane, the molecular formula of this compound is C 20 h 18 o 6 , and named olealignan A, its chemical structure is as follows:

[0038]

[0039] Described compound is called olealignan A, and table 1 is the NMR data of this new compound: 1 H-NMR with 13 C-NMR in deuterated DMSO.

[0040] Table 1. NMR data of the new compounds of the present invention.

[0041]

[0042] The structural identification of a kind of lignan compound extracted and separated from purslane refers to Figure 1-10 , the biological structure identification and deduction of the compound are as follows.

[0043] Oleralignan A: yellow powder, easily soluble in methanol. HR-ESI – - MS gives m / z 353.1021 [M-H] – The quasi-molecular ion peak has a molecular weight of 353.1031. to combine 1 H-NMR, 13 According to C-NMR and...

Embodiment 2

[0053] Example 2 Anti-tumor effect of the new compound of the present invention.

[0054] 1 main material.

[0055] 1.1 Drugs and reagents.

[0056] The new compound used in the experiment was prepared by the above-mentioned method with a purity of 90-99%. It was accurately weighed and diluted with DMSO to the solution required for each dosage group below. DMEM high-glucose medium, fetal bovine serum (Hyclone Company of the United States); penicillin and streptomycin (Hangzhou Sijiqing Company).

[0057] 1.2 Cell lines.

[0058] Human colon cancer cell Caco-2, human breast cancer cell MCF-7, human gastric cancer cell BGC-823, human lung adenocarcinoma cell SPC-A1, human liver cancer cell BEL-7402, human cervical cancer cell Hela-229, ovarian cancer cell Ho-8910, human oral epidermoid carcinoma cells KB (Shanghai Cell Bank, Chinese Academy of Sciences).

[0059] 1.3 Grouping.

[0060] Divided into control group, experimental group and zero adjustment group (culture solutio...

Embodiment 3

[0070] Example 3 Anticholinesterase effect of compounds of the present invention.

[0071] 1 main material.

[0072] 1.1 Drugs and reagents.

[0073] The lignan compound used in the experiment was prepared by the above method, with a purity of 90-99%. Sodium dihydrogen phosphate, disodium hydrogen phosphate (Sinopharm Chemical Reagent Co., Ltd.), physostigmine (Hanxiang Biotechnology), 5,5' -Dithiobisnitrobenzoic acid (DTNB, Shanghai Jinsui Biotechnology Co., Ltd.), acetylcholinesterase (AChE) and acetylthiocholine iodide (ATCI, Dalian Meilun Biological Co., Ltd. Technology Co., Ltd).

[0074] 1.2 Grouping.

[0075] Divided into negative control group, positive control group and experimental group, each group.

[0076] 2. Experimental method.

[0077] 2.1 Sample preparation.

[0078] Precisely weigh the sample and 1 mg of physostigmine, respectively, and use methanol as a solvent to prepare five gradient concentrations of (5, 10, 20, 30, 50 μM / mL). Accurately weigh 7.09...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
degree of unsaturationaaaaaaaaaa
Login to view more

Abstract

The invention relates to the field of traditional Chinese medicine extraction and separation, in particular to a new compound extracted, separated and identified from a purslane medicinal material andan extraction and separation method and application thereof. The invention provides a lignan compound olealignan A extracted from portulaca oleracea and an extraction and separation method and application thereof. The ester compound is prepared by sequentially adopting alcohol decoction extraction, silica gel column chromatography, polyamide column chromatography, ODS medium-pressure column and Sephadex LH-20 purification and liquid phase separation. The extraction and separation method is simple, convenient, quick and environment-friendly, and the compound separated by the method is relatively high in purity and pharmacological experiments prove that the obtained compound has anti-tumor and anti-cholinesterase effects so that the lignan compound olealignan A extracted from purslane and the salt and derivative thereof can be used as natural products to develop new traditional Chinese medicine, and have a wide medical application prospect.

Description

technical field [0001] The invention relates to the field of extraction and separation of traditional Chinese medicines, in particular to a new compound extracted, separated and identified from purslane medicinal material and its extraction and separation method and application, specifically a lignan compound extraction and separation method and its application. Background technique [0002] Purslane (Portulaca oleracea L.), also known as amaranth, longevity vegetable, ant vegetable, is an annual herb of the family Portulacaceae. Purslane is widely distributed and rich in resources. It is one of the 78 wild plants with the same origin of medicine and food stipulated by the Ministry of Health of my country. Purslane is recorded in the 2015 edition of "Pharmacopoeia of the People's Republic of China". It has the functions of clearing heat and detoxifying, cooling blood and stopping bleeding, and stopping dysentery. , hemorrhoids, metrorrhagia, etc. [0003] Modern pharmacolo...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C07D307/92A61P35/00A61P43/00A23L33/105
CPCC07D307/92A61P35/00A61P43/00A23L33/105A23V2002/00A23V2200/30A23V2200/308A23V2250/21A23V2300/14A23V2300/38A23V2300/50Y02A50/30
Inventor 张文洁徐纹英锡相
Owner LIAONING UNIV OF TRADITIONAL CHINESE MEDICINE
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products